Effect of tranexamic acid on mortality in patients with traumatic bleeding: Prespecified analysis of data from randomised controlled trial

BMJ (Online)

Volumn 345, Issue 7877, 2012, Pages

  Roberts, Ian ^a   Perel, Pablo ^a   Prieto Merino, David ^a   Shakur, Haleema ^a   Coats, Tim ^b   Hunt, Beverley J ^c   Lecky, Fiona ^d   Brohi, Karim ^e   Willett, Keith ^f  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; BLEEDING; DEATH; FEMALE; HUMAN; INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; TRAUMATIC BLEEDING; TREATMENT OUTCOME; VEIN THROMBOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RISK; SINGLE BLIND PROCEDURE; THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK ADJUSTMENT; SINGLE-BLIND METHOD; THROMBOSIS; TRANEXAMIC ACID; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 84867279403     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e5839     Document Type: Article

References (13)

1. CRASH-2 Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010;376:23-32.
2. CRASH-2 collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011;377:1096-101.
3. TXA implementation pages - how to do it. www2.le.ac.uk/departments/ cardiovascularsciences/research/population-research-and-clinical-trials/ emergency-medicine-group/ research/injury/txa-implementation-pages-how-to-do-it.
4. Committee on Tactical Combat Casualty Care. Tranexamic acid (TXA) in tactical combat casualty care. Guideline revision recommendation. 2011. www.medicalsci.com/files/tranexamic-acid-txa-in-tactical-combat-casualty-care. pdf.
5. Luz L, Sankarankutty A, Passos E, Rizoli S, Fraga G, Nascimento Jr B. Tranexamic acid for traumatic hemorrhage. Rev Col Bras Cir. 2012;39:77-80.
6. Perel P, Prieto-Merino D, Shakur H, Clayton T, Lecky F, Bouamra O, et al. Predicting early death in patients with traumatic bleeding: development and validation of prognostic model. BMJ 2012;345:e5166.
7. Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ 2010;340:c117.
8. Trauma Audit and Research Network. www.tarn.ac.uk/.
9. Guly HR, Bouamra O, Hatton M, Dark P, Coats T, Driscoll P, et al. Vital signs and estimated blood loss in patients with major trauma: testing the validity of the ATLS classification of hypovolaemic shock. Resuscitation 2011;82:556-9.
10. Godier A, Roberts I, Hunt B. Tranexamic acid: less bleeding and less thrombosis. Crit Care 2012;16:135.
11. Jiménez J, Iribarren J, Lorente L, Rodríguez J, Hernandez D, Nassar I, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care 2007;11:R117.
12. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994;331:1601-6. (Pubitemid 24372057)
13. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012;344:e3054.